APA (7th ed.) Citation

A, H., MR, L., I, K., E, W., AA, P., TP, W., . . . GA, A. (2024). Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. Haematologica, 109(4), 1046. https://doi.org/10.3324/haematol.2023.283723

Chicago Style (17th ed.) Citation

A, Hantel, Luskin MR, Khan I, Warner E, Patel AA, Walsh TP, DeAngelo DJ, Lathan CS, and Abel GA. "Use, Variability, and Justification of Eligibility Criteria for Phase II and III Clinical Trials in Acute Leukemia." Haematologica 109, no. 4 (2024): 1046. https://doi.org/10.3324/haematol.2023.283723.

MLA (9th ed.) Citation

A, Hantel, et al. "Use, Variability, and Justification of Eligibility Criteria for Phase II and III Clinical Trials in Acute Leukemia." Haematologica, vol. 109, no. 4, 2024, p. 1046, https://doi.org/10.3324/haematol.2023.283723.